Company financials

Agilent Technologies

Health Care Life Sciences Tools & Services Santa Clara, California Last filing Dec 22, 2025 · FY2025

                    Revenue
                    FY2025
                
$6.9B
                    3y CAGR +0.5%
                    
                    P17
                    
                    +6.7%
                    
                    Net income
                    FY2025
                
$1.3B
                    Net margin +18.8%
                    
                    P77
                    
                    +1.1%
                    
                    Total assets
                    FY2025
                
$12.7B
                    ROA +10.2%
                    
                    P72
                    
                    +7.4%
                    
                    Operating cash flow
                    FY2025
                
$1.6B
                    FCF margin +16.6%
                    
                    P55
                    
                    -11.0%

20 yrs · FY2006–FY2025 9 filed · 0 derived · 0 blank

1Y 3Y 5Y 10Y

Dollars % of revenue % of assets YoY % CAGR

Running CAGR since the earliest displayed year.

Balance Sheet

Assets, liabilities, and equity

31 accounts · 3 years

Total assets $12.7B

Total liabilities $6.0B

Shareholders equity $6.7B

Account	2025	2024	2023
Assets
Cash and Cash Equivalents	+6.1%	-16.4%	—
Short Term Investments	—	—	—
Accounts Receivable	+7.3%	+2.6%	—
Inventory	-0.3%	-5.7%	—
Prepaid Expenses	+3.4%	+21.9%	—
Other Current Assets	+3.4%	+21.9%	—
Total Current Assets	+4.8%	-5.4%	—
Property,Plant and Equipment	+26.2%	+40.0%	—
Operating Lease Assets	+9.0%	+14.9%	—
Goodwill	+6.3%	+13.1%	—
Intangible Assets	-3.2%	+15.2%	—
Long Term Investments	-9.9%	+6.7%	—
Other Noncurrent Assets	+22.3%	+28.5%	—
Total Assets	+8.7%	+10.1%	—
Liabilities
Accounts Payable	+16.8%	+29.2%	—
Accrued Liabilities	-0.1%	+17.1%	—
Deferred Revenue	+11.2%	+7.7%	—
Current Portion of Long Term Debt	—	—	—
Total Current Liabilities	+21.0%	+18.2%	—
Long Term Debt	+5.6%	+22.3%	—
Deferred Revenue Noncurrent	+11.2%	+7.7%	—
Other Noncurrent Liabilities	-1.5%	+21.2%	—
Total Liabilities	+10.3%	+20.9%	—
Equity
Preferred Stock	—	—	—
Common Stock	+0.0%	+0.0%	—
Additional Paid In Capital	+1.7%	+1.2%	—
Retained Earnings	+33.3%	-4.1%	—
Treasury Stock	—	—	—
Accumulated Other Comprehensive Income	—	—	—
Total Stockholders Equity	+7.4%	+0.9%	—
Total Liabilitiesand Equity	+8.7%	+10.1%	—

Income Statement

Revenue, expense, and profitability

20 accounts · 3 years

Revenue $6.9B

Operating income $1.5B

Net income $1.3B

Account	2025	2024	2023
IncomeStatement
Revenues Total Revenue	+0.8%	-4.7%	—
Expenses Cost of Revenue	-0.9%	-11.7%	—
Expenses Research and Development	-2.7%	-0.4%	—
Expenses Selling,General and Administrative	+2.3%	-4.0%	—
Expenses Depreciation and Amortization	+3.1%	-5.2%	—
Expenses Share Based Compensation	+7.4%	+16.2%	—
Expenses Restructuring and Asset Impairment	+33.5%	+65.2%	—
Expenses Operating Expenses	-0.1%	-8.4%	—
Other Income Expense Operating Income	+4.7%	+10.2%	—
Other Income Expense Interest Income	+10.3%	+56.9%	—
Other Income Expense Interest Expense	+8.6%	+1.1%	—
Other Income Expense Other Income/expense	-57.4%	+48.5%	—
Other Income Expense Income Before Tax	+3.5%	+13.6%	—
Income Tax Income Tax Expense	+15.5%	+134.3%	—
net Income net Income	+2.5%	+4.0%	—
net Income Comprehensive Income	+4.7%	+4.0%	—
Earnings Per Share Basic Eps	+4.3%	+5.2%	—
Earnings Per Share Diluted Eps	+4.4%	+5.7%	—
Earnings Per Share Weighted Average Shares Basic	-1.7%	-1.4%	—
Earnings Per Share Weighted Average Shares Diluted	-1.9%	-1.7%	—

Cash Flow Statement

Operating, investing, and financing flows

22 accounts · 3 years

Operating cash flow $1.6B

Investing cash flow $-394.0M

Financing cash flow $-715.0M

Account	2025	2024	2023
CashFlow
Operating Activities net Income	+2.5%	+4.0%	—
Operating Activities Depreciation and Amortization	+3.1%	-5.2%	—
Operating Activities Stock Based Compensation	+7.4%	+16.2%	—
Operating Activities Deferred Income Taxes	—	—	—
Operating Activities Changes In Operating Assets and Liabilities	+109.4%	+174.7%	—
Operating Activities net Cash From Operating Activities	-6.2%	-1.2%	—
Investing Activities Capital Expenditures	+16.9%	+26.8%	—
Investing Activities Business Acquisitions	—	+1590.2%	—
Investing Activities Purchases of Investments	—	-37.5%	—
Investing Activities net Cash From Investing Activities	—	—	—
Financing Activities Proceeds From Debt	—	—	—
Financing Activities Repayment of Debt	—	—	—
Financing Activities Repurchase of Common Stock	-14.0%	+100.0%	—
Financing Activities Dividends Paid	+3.2%	+3.4%	—
Financing Activities Proceeds From Stock Issuance	+3.7%	+14.9%	—
Financing Activities Tax Withholding On Stock Based Compensation	-26.7%	-44.4%	—
Financing Activities Other Financing Activities	—	—	—
Financing Activities net Cash From Financing Activities	—	—	—
Cash Reconciliation Effect of Exchange Rate On Cash	+34.2%	—	—
Cash Reconciliation net Change In Cash	-7.5%	—	—
Cash Reconciliation Cash At Beginning of Period	+6.0%	-16.4%	—
Cash Reconciliation Cash At End of Period	+6.0%	-16.4%	—

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 3 years

Ratio	2025	2024	2023
Profitability
Gross margin	+52.4%	+54.3%	+50.7%
Operating margin	+21.3%	+22.9%	+19.8%
Net margin	+18.8%	+19.8%	+18.1%
FCF margin	+16.6%	+21.1%	+21.6%
Growth
Revenue CAGR (3y)	+0.5%	+1.0%	+8.6%
Returns
ROE	+19.3%	+21.9%	+21.2%
ROA	+10.2%	+10.9%	+11.5%
ROIC	+16.2%	+15.8%	+17.9%
Liquidity
Current ratio	1.96x	2.09x	2.61x
Quick ratio	1.40x	1.40x	1.80x
Leverage
D/E	0.89x	1.01x	0.84x
Interest coverage	13.21x	15.50x	14.21x
Efficiency
Asset turnover	0.55x	0.55x	0.63x
Cash conversion cycle	+128d	+127d	+135d

Valuation

Price against fundamentals

A $115 · 2026-04-02 · 166d old · FY2025

Market cap $32.9B

P/E 25.26x

P/S 4.74x

P/B 4.88x

EV $34.5B

EV/EBITDA 19.51x

FCF yield +3.5%

Dividend yield +0.9%

Notes

Your annotations

Not watched